vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Midland States Bancorp, Inc. (MSBI). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $79.5M, roughly 1.5× Midland States Bancorp, Inc.). Midland States Bancorp, Inc. runs the higher net margin — 23.2% vs 4.2%, a 19.0% gap on every dollar of revenue. Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -6.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Rainier Bancorporation was the Seattle-based parent corporation of Rainier National Bank, a Washington state bank with branches throughout the state. Rainier traced its roots back to the National Bank of Commerce, which was founded by Richard Holyoke in 1889. The name Rainier National Bank was adopted in 1974. Rainier Bancorp expanded into Alaska with the purchase of Anchorage's People's Bank & Trust in 1983 and into Oregon with the purchase of Gresham's Mount Hood Security Bank in 1986, expa...

CLB vs MSBI — Head-to-Head

Bigger by revenue
CLB
CLB
1.5× larger
CLB
$121.8M
$79.5M
MSBI
Higher net margin
MSBI
MSBI
19.0% more per $
MSBI
23.2%
4.2%
CLB
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-6.4%
MSBI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
MSBI
MSBI
Revenue
$121.8M
$79.5M
Net Profit
$5.1M
$18.5M
Gross Margin
Operating Margin
1.5%
Net Margin
4.2%
23.2%
Revenue YoY
-1.4%
Net Profit YoY
739.3%
EPS (diluted)
$0.11
$0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
MSBI
MSBI
Q1 26
$121.8M
$79.5M
Q4 25
$138.3M
$85.6M
Q3 25
$134.5M
$81.1M
Q2 25
$130.2M
$82.2M
Q1 25
$123.6M
$76.1M
Q4 24
$129.2M
$93.9M
Q3 24
$134.4M
$92.7M
Q2 24
$130.6M
$90.9M
Net Profit
CLB
CLB
MSBI
MSBI
Q1 26
$5.1M
$18.5M
Q4 25
$4.9M
$-2.9M
Q3 25
$14.2M
$7.6M
Q2 25
$10.6M
$12.0M
Q1 25
$-154.0K
$-141.0M
Q4 24
$7.4M
$-30.8M
Q3 24
$11.7M
$20.4M
Q2 24
$9.0M
$25.7M
Gross Margin
CLB
CLB
MSBI
MSBI
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
MSBI
MSBI
Q1 26
1.5%
Q4 25
11.5%
-5.5%
Q3 25
15.6%
13.9%
Q2 25
11.7%
18.1%
Q1 25
3.6%
-181.2%
Q4 24
11.0%
-66.5%
Q3 24
14.7%
26.9%
Q2 24
12.3%
35.0%
Net Margin
CLB
CLB
MSBI
MSBI
Q1 26
4.2%
23.2%
Q4 25
3.6%
-4.9%
Q3 25
10.6%
9.3%
Q2 25
8.2%
14.6%
Q1 25
-0.1%
-185.4%
Q4 24
5.7%
-52.5%
Q3 24
8.7%
22.1%
Q2 24
6.9%
28.3%
EPS (diluted)
CLB
CLB
MSBI
MSBI
Q1 26
$0.11
$0.74
Q4 25
$0.11
$-0.22
Q3 25
$0.30
$0.24
Q2 25
$0.22
$0.44
Q1 25
$0.00
$-6.58
Q4 24
$0.15
$-1.49
Q3 24
$0.25
$0.83
Q2 24
$0.19
$1.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
MSBI
MSBI
Cash + ST InvestmentsLiquidity on hand
$22.8M
$89.4M
Total DebtLower is stronger
$33.2M
Stockholders' EquityBook value
$275.1M
$569.5M
Total Assets
$587.7M
$6.5B
Debt / EquityLower = less leverage
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
MSBI
MSBI
Q1 26
$22.8M
$89.4M
Q4 25
$22.7M
$127.8M
Q3 25
$25.6M
$166.1M
Q2 25
$31.2M
$176.6M
Q1 25
$22.1M
$102.0M
Q4 24
$19.2M
$114.8M
Q3 24
$21.5M
$121.9M
Q2 24
$17.7M
$124.6M
Total Debt
CLB
CLB
MSBI
MSBI
Q1 26
$33.2M
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
MSBI
MSBI
Q1 26
$275.1M
$569.5M
Q4 25
$266.0M
$565.5M
Q3 25
$271.3M
$584.0M
Q2 25
$261.3M
$573.7M
Q1 25
$253.4M
$571.4M
Q4 24
$246.6M
$710.8M
Q3 24
$250.7M
$771.2M
Q2 24
$240.3M
$736.8M
Total Assets
CLB
CLB
MSBI
MSBI
Q1 26
$587.7M
$6.5B
Q4 25
$584.0M
$6.5B
Q3 25
$591.4M
$6.9B
Q2 25
$602.1M
$7.1B
Q1 25
$591.5M
$7.3B
Q4 24
$585.1M
$7.5B
Q3 24
$600.5M
$7.7B
Q2 24
$597.8M
$7.7B
Debt / Equity
CLB
CLB
MSBI
MSBI
Q1 26
0.06×
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
MSBI
MSBI
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
MSBI
MSBI
Q1 26
$4.0M
Q4 25
$7.9M
$125.7M
Q3 25
$8.5M
$80.0M
Q2 25
$13.9M
$28.1M
Q1 25
$6.7M
$24.7M
Q4 24
$20.6M
$176.5M
Q3 24
$13.1M
$46.5M
Q2 24
$17.1M
$31.4M
Free Cash Flow
CLB
CLB
MSBI
MSBI
Q1 26
$517.0K
Q4 25
$5.0M
$120.3M
Q3 25
$6.5M
$78.6M
Q2 25
$10.4M
$26.7M
Q1 25
$3.9M
$22.9M
Q4 24
$17.4M
$169.6M
Q3 24
$10.4M
$44.4M
Q2 24
$14.3M
$29.9M
FCF Margin
CLB
CLB
MSBI
MSBI
Q1 26
0.4%
Q4 25
3.6%
140.6%
Q3 25
4.8%
96.9%
Q2 25
8.0%
32.4%
Q1 25
3.1%
30.1%
Q4 24
13.4%
180.6%
Q3 24
7.7%
47.9%
Q2 24
10.9%
32.9%
Capex Intensity
CLB
CLB
MSBI
MSBI
Q1 26
Q4 25
2.1%
6.2%
Q3 25
1.5%
1.7%
Q2 25
2.7%
1.7%
Q1 25
2.3%
2.4%
Q4 24
2.5%
7.3%
Q3 24
2.0%
2.3%
Q2 24
2.2%
1.7%
Cash Conversion
CLB
CLB
MSBI
MSBI
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
10.58×
Q2 25
1.31×
2.33×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
2.28×
Q2 24
1.90×
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

MSBI
MSBI

Net Interest Income$57.4M72%
Noninterest Income$22.1M28%

Related Comparisons